Genedrive Plc
LSE:GDR.L
Sector
Location
Market Cap
USD 11.13 M
Share Price
USD 0.02
Avg Daily Volume
6,362,967
Change (1 day)
-4.13%
Change (1 year)
-64.16%
Change (YTD)
-41.70%
Genedrive Plc Income Statement 2014 - 2024
This table shows the Income Statement for Genedrive Plc going from 2014 until 2024. The income statement, also known as the profit and loss statement, is a financial statement that provides a summary of a company's revenues, expenses, and net income over a specific period (such as a quarter or a year). It shows the company's ability to generate revenue, manage expenses, and ultimately determine its profitability.
Income Statement
| Annual data in millions of USD, except per share data | Trend |
|---|
Competitors
Roche Holding AG
USD 345.06
RO.SW
-6.70
-1.91%
Abbott Laboratories
USD 126.54
ABT
+0.90
0.72%
Thermo Fisher Scientific Inc.
USD 478.32
TMO
+3.29
0.69%
Boston Scientific Corporation
USD 106.14
BSX
-0.07
-0.07%
Siemens Healthineers AG
USD 56.32
SHL.DE
+0.05
0.09%
Becton, Dickinson and Company
USD 185.32
BDX
+1.69
0.92%
GE HealthCare Technologies Inc.
USD 77.61
GEHC
+0.84
1.09%
Agilent Technologies, Inc.
USD 120.18
A
-0.17
-0.14%
Laboratory Corporation of America Holdings
USD 264.96
LH
-2.73
-1.02%
Natera, Inc.
USD 138.90
NTRA
-2.17
-1.54%
bioMérieux S.A.
USD 147.11
BIM.PA
-0.43
-0.29%
Baxter International Inc.
USD 29.22
BAX
+0.45
1.56%
Revvity, Inc.
USD 103.67
RVTY
+1.70
1.67%
Qiagen N.V.
USD 51.79
QGEN
+0.56
1.09%
Tempus AI, Inc.
USD 64.49
TEM
+1.15
1.82%